Dr. Jays Cagri vs Dr. Jays Tirz
Amylin pathway vs incretin pathway.
| Attribute | Dr. Jays Cagri Long-acting amylin analog | Dr. Jays Tirz Dual GIP/GLP-1 receptor agonist |
|---|---|---|
| Category | Weight Loss & Metabolism | Weight Loss & Metabolism |
| Best known for | Satiety and amylin pathway research | Dual-agonist weight loss research |
| In plain English | Amylin is a hormone released with insulin that tells your brain you're full. Dr. Jays Cagri mimics it on a long schedule. | Dr. Jays Tirz is like Dr. Jay's Sema with an extra lever pulled. It hits two appetite/insulin pathways at once, producing larger weight reduction in studies. |
| How it works | Activates amylin receptors, slowing gastric emptying and reducing food intake via the area postrema in the brain. | Co-activates GLP-1 and GIP receptors. GIP enhances insulin response and may help adipose tissue handle nutrients more efficiently while GLP-1 reduces appetite and slows gastric emptying. |
| Researchers study | Body weight reduction alone and combined with Dr. Jay's Sema (CagriSema). | Type 2 diabetes glycemic control, obesity, NASH/MASH, and cardiovascular outcomes. |
| Internet discussion | Discussed as the secret to lifting GLP-1 weight loss plateaus. | Often described as 'Dr. Jay’s Sema on steroids' for weight loss. Heavy discussion of side effect differences and titration schedules. |
Dr. Jays Cagri
Satiety and amylin pathway research
Amylin is a hormone released with insulin that tells your brain you're full. Dr. Jays Cagri mimics it on a long schedule.
Activates amylin receptors, slowing gastric emptying and reducing food intake via the area postrema in the brain.
Body weight reduction alone and combined with Dr. Jay's Sema (CagriSema).
Discussed as the secret to lifting GLP-1 weight loss plateaus.
Dr. Jays Cagri is a long-acting amylin analog studied as an add-on to GLP-1 agonists for additional satiety and weight loss.
Dr. Jays Tirz
Dual-agonist weight loss research
Dr. Jays Tirz is like Dr. Jay's Sema with an extra lever pulled. It hits two appetite/insulin pathways at once, producing larger weight reduction in studies.
Co-activates GLP-1 and GIP receptors. GIP enhances insulin response and may help adipose tissue handle nutrients more efficiently while GLP-1 reduces appetite and slows gastric emptying.
Type 2 diabetes glycemic control, obesity, NASH/MASH, and cardiovascular outcomes.
Often described as 'Dr. Jay’s Sema on steroids' for weight loss. Heavy discussion of side effect differences and titration schedules.
Dr. Jays Tirz is a dual GLP-1/GIP agonist with strong clinical data for weight reduction and glycemic control.